Investigators reported that the long non‑coding RNA CYTOR modulates pathways linked to metastasis and chemoresistance in triple‑negative breast cancer (TNBC), revealing a potential molecular lever for intervention. The study by Erdağ, Ergene and Yıldız details CYTOR’s interactions with signaling networks that promote invasive phenotypes and reduce drug sensitivity. LncRNAs are non‑protein‑coding transcripts that regulate gene expression at multiple levels; CYTOR’s role in TNBC positions it as a candidate biomarker and therapeutic target for one of the hardest‑to‑treat breast cancer subtypes. Follow‑up work will be needed to validate targetability and safety in preclinical models.